ZHANG Xi-lin, HUANG Dan, WU Yan-ting, CHEN Xiao-yan. Clinical research of different regimens in patients with pulmonary tuberculosis combined with type B hepatitis[J]. Chinese Journal of Antituberculosis, 2011, 33(9): 578-581.
[1]严碧涯,端木宏瑾.结核病学. 北京:北京出版社,2003,312-339.[2]梁晓峰,陈园生,王晓军,等.中国3岁以上人群乙型肝炎血清流行病学研究.中华流行病学杂志,2005,26(9):655-658.[3]中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南.中华内科杂志,2006,45(2):162-170.[4]中华人民共和国卫生行业标准.肺结核诊断标准.北京:人民卫生出版社,2008:1-3.[5]中华医学会结核病学分会.肺结核诊断和治疗指南.中华结核和呼吸杂志,2001,24(2):70-74.[6]许建明,徐张巍,胡祥鹏. 112例药物性肝损伤的临床关联性评价.中华消化杂志,2005,25(8):451-453.[7]Mommeja-Marin H,Mondou E,Blum MR,et al. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection:analysis and review of the literature. Hepatology,2003,37(6):1309-1319.
LIU Er-yong, CHENG Shi-ming, LAI Yu-ji, WANG Dong-mei, LI Tao, WANG Li-ming, WANG Ni, XU Xiao-yu, ZHOU Lin.
Progress in TB preventive therapy
[J]. Chinese Journal of Antituberculosis, 2014, 36(1): 59-63.